3 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
Follow digital ulcers: new trials by email Literature Review of digital ulcers trials Research Report on digital ulcers
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-Label Study of Oral Treprostinil in Digital Ulcers treprostinil diethanolamine - Systemic Sclerosis | Phase 2 | Terminated | United Therapeutics | 115 | 2009-09-01 | 2024-06-18 |
| Safety and Efficacy Study of MRE0094 to Treat Large, Single or Multiple, Chronic, Neuropathic, Diabetic Foot Ulcers MRE0094, Vehicle gel - Foot Ulcer, Diabetic, Diabetes Complications | Phase 2 | Terminated | Pfizer | 16 | 2006-06-01 | 2012-06-01 |
| Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis iloprost, iloprost low dose, iloprost therapy up to 2 ng/kg x min - Systemic Sclerosis | Phase 2 | Terminated | Charite University, Berlin, Germany | 50 | 1997-09-01 | 2008-02-25 |
Scleroderma, Systemic (2) · Diabetes Complications (1) · Diabetic Foot (1) · Foot Ulcer (1) · Scleroderma, Diffuse (1) · Vascular Diseases (1)
Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Cardiovascular Diseases (2) · Connective Tissue Diseases (2) · Diabetes Mellitus (1) · Diabetic Angiopathies (1) · Diabetic Neuropathies (1) · Endocrine System Diseases (1) · Foot Diseases (1) · Leg Ulcer (1) · Skin Ulcer (1) · Vascular Diseases (1)
2-(2-(4-chlorophenyl)ethoxy)adenosine (1) · Iloprost (1) · treprostinil (1)
Charite University, Berlin, Germany (1) · Pfizer (1) · United Therapeutics (1)
United States (2) · Canada (1) · Germany (1) · United Kingdom (1)
Gabriela Riemekasten, MD (1) · James Seibold, MD (1) · Robert L. Rolleri, Pharm.D. (1)